Benzoyl peroxide 0.05 MG/MG / clindamycin 0.01 MG/MG Topical Gel — RxCUI 358917
RxNorm drug concept · Semantic clinical drug
RxCUI 358917
Semantic clinical drug · SCD
● Current RxNorm concept 16 FDA products
23 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI358917
Official nameBenzoyl peroxide 0.05 MG/MG / clindamycin 0.01 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbenzoyl peroxide 5 % / clindamycin 1 % Topical Gel; clindamycin phosphate 1 % / benzoyl peroxide 5 % Topical Gel; benzoyl peroxide 5 % / clindamycin 1 % (as clindamycin phosphate 1.2 % ) Topical Gel
FDA products mapped16
Package NDCs mapped23
Reported Medicaid activity (SDUD)151,765 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Clindamycin and Benzoyl Peroxide Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats acne vulgaris — regular acne — by attacking the bacteria on your skin and helping to clear clogged pores. The clindamycin fights the bacteria that contribute to breakouts...
- What is this gel actually supposed to do for my acne?
- Start by washing your face gently with a mild soap, rinsing with warm water, and patting it completely dry. Then apply just a pea-sized amount — that's really all you need — and sp...
- Some redness, burning, itching, and flaking in the first few weeks is common and usually means your skin is adjusting. These reactions often peak around week 4 and tend to improve...
🕸️ Concept Web — How Benzoyl peroxide 0.05 MG/MG / clindamycin 0.01 M... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Benzoyl peroxide 0.05 MG/MG / clindamycin 0.01 MG/MG Topical Gel
RxCUI 358917 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Benzoyl peroxide
1418IN -
Clindamycin
2582IN -
Benzoyl peroxide / clindamycin
646781MIN
-
Benzoyl peroxide
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Benzoyl peroxide / clindamycin Topical Gel
379074SCDF -
Benzoyl peroxide / clindamycin Topical Product
1152978SCDG -
Topical Gel
346286DF -
Topical Product
1151122DFG
-
Benzoyl peroxide / clindamycin Topical Gel
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Benzoyl peroxide 0.05 MG/MG
328718SCDC -
Clindamycin 0.01 MG/MG
328342SCDC
-
Benzoyl peroxide 0.05 MG/MG
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Benzoyl peroxide 0.05 MG/MG
SCDC · 328718 -
Clindamycin 0.01 MG/MG
SCDC · 328342 -
Benzoyl peroxide / clindamycin Topical Gel
SCDF · 379074 -
Benzoyl peroxide / clindamycin Topical Product
SCDG · 1152978
📦 FDA Products & Package NDCs
16 products · 23 package NDCs
23 package NDCs map to RxCUI 358917 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-8688-35 | 1 KIT in 1 CARTON (0378-8688-35) * 5 g in 1 BOTTLE, PLASTI... | Clindamycin Phosphate and Benzoyl Peroxide | Mylan Pharmaceuticals Inc. | 2014-09-19 |
| 00378-8688-54 | 1 KIT in 1 CARTON (0378-8688-54) * 10 g in 1 BOTTLE, PLAST... | Clindamycin Phosphate and Benzoyl Peroxide | Mylan Pharmaceuticals Inc. | 2009-08-25 |
| 16714-0984-25 | 1 JAR in 1 CARTON (16714-984-25) / 25 g in 1 JAR | clindamycin and benzoyl peroxide | NorthStar RxLLC | 2019-07-01 |
| 16714-0984-50 | 1 JAR in 1 CARTON (16714-984-50) / 50 g in 1 JAR | clindamycin and benzoyl peroxide | NorthStar RxLLC | 2019-07-01 |
| 21922-0068-43 | 1 KIT in 1 CARTON (21922-068-43) * 20 g in 1 JAR (21922-06... | Clindamycin and Benzoyl Peroxide | Encube Ethicals, Inc. | 2025-10-07 |
| 21922-0068-44 | 1 KIT in 1 CARTON (21922-068-44) * 20 g in 1 JAR (21922-06... | Clindamycin and Benzoyl Peroxide | Encube Ethicals, Inc. | 2025-10-07 |
| 21922-0068-45 | 1 KIT in 1 CARTON (21922-068-45) * 20 g in 1 JAR (21922-06... | Clindamycin and Benzoyl Peroxide | Encube Ethicals, Inc. | 2025-10-07 |
| 21922-0068-46 | 1 KIT in 1 CARTON (21922-068-46) * 20 g in 1 JAR (21922-06... | Clindamycin and Benzoyl Peroxide | Encube Ethicals, Inc. | 2025-10-07 |
| 45802-0507-02 | 1 KIT in 1 CARTON (45802-507-02) * .6 g in 1 VIAL * 39.4... | CLINDAMYCIN AND BENZOYL PEROXIDE | Padagis Israel Pharmaceuticals Ltd | 2015-09-22 |
| 45802-0507-04 | 1 KIT in 1 CARTON (45802-507-04) * .6 g in 1 VIAL * 39.4... | clindamycin and benzoyl peroxide | Padagis Israel Pharmaceuticals Ltd | 2016-04-26 |
| 45802-0509-01 | 1 KIT in 1 CARTON (45802-509-01) * .3 g in 1 VIAL (45802-7... | clindamycin and benzoyl peroxide | Padagis Israel Pharmaceuticals Ltd | 2021-02-03 |
| 45802-0510-03 | 1 KIT in 1 CARTON (45802-510-03) * .4 g in 1 VIAL (45802-7... | clindamycin and benzoyl peroxide | Padagis Israel Pharmaceuticals Ltd | 2021-03-08 |
| 51672-1381-02 | 1 KIT in 1 CARTON (51672-1381-2) * 5 g in 1 BOTTLE, PLASTI... | Clindamycin Phosphate and Benzoyl Peroxide | Sun Pharmaceutical Industries, Inc. | 2018-05-25 |
| 51672-1381-04 | 1 KIT in 1 CARTON (51672-1381-4) * 10 g in 1 BOTTLE, PLAST... | Clindamycin Phosphate and Benzoyl Peroxide | Sun Pharmaceutical Industries, Inc. | 2018-05-25 |
| 51672-1381-05 | 1 KIT in 1 CARTON (51672-1381-5) * 7 g in 1 BOTTLE, PLASTI... | Clindamycin Phosphate and Benzoyl Peroxide | Sun Pharmaceutical Industries, Inc. | 2020-01-21 |
| 51672-1381-06 | 1 KIT in 1 CARTON (51672-1381-6) * 10 g in 1 BOTTLE, PLAST... | Clindamycin Phosphate and Benzoyl Peroxide | Sun Pharmaceutical Industries, Inc. | 2020-01-21 |
| 68462-0486-19 | 1 JAR in 1 CARTON (68462-486-19) / 25 g in 1 JAR | clindamycin and benzoyl peroxide | Glenmark Pharmaceuticals Inc., USA | 2019-03-14 |
| 68462-0486-24 | 1 JAR in 1 CARTON (68462-486-24) / 35 g in 1 JAR | clindamycin and benzoyl peroxide | Glenmark Pharmaceuticals Inc., USA | 2019-05-07 |
| 68462-0486-27 | 1 JAR in 1 CARTON (68462-486-27) / 50 g in 1 JAR | clindamycin and benzoyl peroxide | Glenmark Pharmaceuticals Inc., USA | 2019-03-14 |
| 68462-0859-24 | 1 BOTTLE, PUMP in 1 CARTON (68462-859-24) / 35 g in 1 BOTTL... | clindamycin and benzoyl peroxide | Glenmark Pharmaceuticals Inc., USA | 2021-09-24 |
| 68462-0859-27 | 1 BOTTLE, PUMP in 1 CARTON (68462-859-27) / 50 g in 1 BOTTL... | clindamycin and benzoyl peroxide | Glenmark Pharmaceuticals Inc., USA | 2021-09-24 |
| 70771-1450-04 | 1 TUBE in 1 CARTON (70771-1450-4) / 45 g in 1 TUBE | Clindamycin Phosphate and Benzoyl Peroxide | Zydus Lifesciences Limited | 2019-03-07 |
| 72162-2074-02 | 1 KIT in 1 CARTON (72162-2074-2) * .6 g in 1 VIAL * 39.4... | CLINDAMYCIN AND BENZOYL PEROXIDE | Bryant Ranch Prepack | 2023-08-15 |
Observed labelers:
Glenmark Pharmaceuticals Inc., USA (5) ·
Encube Ethicals, Inc. (4) ·
Padagis Israel Pharmaceuticals Ltd (4) ·
Sun Pharmaceutical Industries, Inc. (4) ·
Mylan Pharmaceuticals Inc. (2) ·
NorthStar RxLLC (2)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.